Indicators

Markets:

News

Latest News about BMY

Recent news which mentions BMY

< Previous 1 2 3 4 5 6 7 8 9

...

Syros Pharmaceuticals Stock Sinks As Pivotal Blood Cancer Trial Flunks, Triggers Loan Default

November 13, 2024

AbbVie's Schizophrenia Failure Disappoints But Analysts Show Confidence In Immunology Portfolio

November 12, 2024

This Bristol-Myers Squibb Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday

November 12, 2024

Bristol-Myers Squibb's $14 Billion Potential - Analyst Upgrades Stock

November 12, 2024

What's Going On With Bristol-Myers Squibb Shares Monday?

November 11, 2024

AbbVie's Emraclidine For Schizophrenia 'Surprisingly Disappoints,' Analyst Says Pipeline Is Underappreciated

November 11, 2024

Private Equity Triton Partners Takes Around 10% Stake In Evotec, Reportedly Mulls Potential Takeover Deal

November 11, 2024

AbbVie Stock Slips As $9 Billion Schizophrenia Studies Flunk, Bristol-Myers Stock Surges

November 11, 2024

MARA Holdings, RadNet, Bit Digital, Coinbase And Other Big Stocks Moving Higher On Monday

November 11, 2024

Bristol-Myers Squibb Leads Biopharma Recovery With Almost 25% Growth In Market Cap, But Novo Nordisk And Lilly Suffer Market Setbacks

November 08, 2024

Generic Drug Maker Teva Clocks 13% Jump In Q3 Revenues, Tightens Annual Forecast

November 06, 2024

Summit Therapeutics 'Unique Investment In Oncology,' Lead Drug Candidate Shows Promise Over Keytruda And Opdivo

November 04, 2024

How Is The Market Feeling About Bristol-Myers Squibb?

November 04, 2024

Bristol Myers Squibb Expects New Schizophrenia Treatment To Boost Long-Term Growth, Analysts Remain Cautious

November 01, 2024

Stocks Tumble, Nasdaq 100 Selloffs As Tech Giants Disappoint, Crypto Companies Plummet: What's Driving Markets Thursday?

October 31, 2024

Bristol Myers Squibb (BMY) Q3 2024 Earnings Call Transcript

October 31, 2024

Bristol Myers Squibb Boosts 2024 Outlook On Strong Demand For Blood Thinner Med, New Drugs Drive Q3 Profit

October 31, 2024

Positive Outlook For Novartis As Company Capitalizes On Growing Treatment Opportunities, Analyst Highlights

October 30, 2024

Lyell Immunopharma Downgraded, Analyst Flags Concerns Over Acquisition Strategy

October 30, 2024

Unpacking the Latest Options Trading Trends in Bristol-Myers Squibb

October 23, 2024

800% Upside For This Biotech Stock - Analyst Initiates Coverage On Bladder Cancer Focused ImmunityBio

October 23, 2024

Why Is Evotec Stock Gaining Today?

October 23, 2024

Alumis' Investigational Lead Candidate Supports Superior Profile Than Bristol Myers' Commercialized Drug, Analyst Sees 170% Stock Upside

October 17, 2024

Johnson & Johnson Beats Wall Street Estimates. Is It Time to Buy, Sell, or Hold?

October 16, 2024

Cancer-Focused Perspective Therapeutics Stock Trades Lower After Drug Study Report

October 11, 2024

Reviva Pharmaceuticals Schizophrenia Drug Demonstrates Strong Efficacy On Heels Of Bristol Myers, FDA Approval: Analyst

October 07, 2024

Unveiling 11 Analyst Insights On Bristol-Myers Squibb

October 07, 2024

10 Health Care Stocks Whale Activity In Today's Session

October 07, 2024

S&P 500 Could Reach 6,300 In 12 Months, Says Goldman Sachs, Driven By 'Strong AI Demand' And 'Margin Expansion'

October 07, 2024

Pfizer Stock Slump: Will Starboard's Billion-Dollar Bet Spark Rebound?

October 07, 2024

< Previous 1 2 3 4 5 6 7 8 9

...

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.